• Publications
  • Influence
Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients.
This study evaluated the efficacy and tolerability of budesonide in an aqueous nasal spray (BANS) in patients with chronic rhinosinusitis. In this double-blind, placebo-controlled, multicentre,Expand
  • 103
  • 7
Efficacy of an Aqueous and a Powder Formulation of Nasal Budesonide Compared in Patients with Nasal Polyps
Nasal polyps are commonly treated surgically. Intranasal administration of topical corticosteroids has gained increased acceptance as a treatment alternative. The aim of our study was to compare theExpand
  • 90
  • 3
Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps.
OBJECTIVE To assess the efficacy and tolerability of once-daily treatment with budesonide aqueous nasal spray in patients with nasal polyps. DESIGN Randomized, double-blind, placebo-controlled,Expand
  • 57
  • 1
A Comparison of Aqueous Suspensions of Budesonide Nasal Spray (128 μg and 256 μg Once Daily) and Fluticasone Propionate Nasal Spray (200 μg Once Daily) in the Treatment of Adult Patients with
The efficacy of aqueous suspensions of budesonide nasal spray and fluticasone propionate nasal spray, in the treatment of seasonal allergic rhinitis, was compared in a large, placebo-controlled,Expand
  • 33
  • 1
Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen‐season model of allergic rhinitis
Background Rofleponide palmitate is an esterified glucocorticosteroid pro‐drug with a promising pre‐clinical profile designed to deliver topical airway treatment for allergic rhinitis and asthma in aExpand
  • 21
  • 1
Ostial function in allergic rhinitis.
In order to evaluate the maxillary ostial function a double-blind, group comparative study with intranasal budesonide and placebo was carried out in 20 adult patients suffering from seasonalExpand
  • 8
  • 1
A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis.
A randomized, double-blind, placebo-controlled trial was performed to assess the efficacy of once daily budesonide in patients with nasal polyps. After a 2-week run-in period, 157 patients withExpand
  • 47
Randomised trial of efficacy and tolerability of budesonide aqueous nasal spray in patients with chronic rhinosinusitis
This study evaluated the efficacy and tolerability of budesonide in an aqueous nasal spray (BANS) in patients with chronic rhinosinusitis. In this double-blind, placebo-controlled, multicentre,Expand
  • 17
Clinical efficacy of budesonide in the treatment of eczematous external otitis
SummarySixty patients with mild to moderate forms of eczematous otitis externa were treated with budesonide and placebo in a double-blind controlled study using parallel groups. Each treatment periodExpand
  • 20